168 related articles for article (PubMed ID: 1665384)
1. Cannabinoid-induced antinociception is mediated by a spinal alpha 2-noradrenergic mechanism.
Lichtman AH; Martin BR
Brain Res; 1991 Sep; 559(2):309-14. PubMed ID: 1665384
[TBL] [Abstract][Full Text] [Related]
2. Spinal and supraspinal components of cannabinoid-induced antinociception.
Lichtman AH; Martin BR
J Pharmacol Exp Ther; 1991 Aug; 258(2):517-23. PubMed ID: 1650831
[TBL] [Abstract][Full Text] [Related]
3. Differential mechanisms mediating descending pain controls for antinociception induced by supraspinally administered endomorphin-1 and endomorphin-2 in the mouse.
Ohsawa M; Mizoguchi H; Narita M; Chu M; Nagase H; Tseng LF
J Pharmacol Exp Ther; 2000 Sep; 294(3):1106-11. PubMed ID: 10945866
[TBL] [Abstract][Full Text] [Related]
4. Systemic cannabinoids produce CB₁-mediated antinociception by activation of descending serotonergic pathways that act upon spinal 5-HT(7) and 5-HT(2A) receptors.
Seyrek M; Kahraman S; Deveci MS; Yesilyurt O; Dogrul A
Eur J Pharmacol; 2010 Dec; 649(1-3):183-94. PubMed ID: 20868676
[TBL] [Abstract][Full Text] [Related]
5. Characterization of anandamide- and fluoroanandamide-induced antinociception and cross-tolerance to delta 9-THC after intrathecal administration to mice: blockade of delta 9-THC-induced antinociception.
Welch SP; Dunlow LD; Patrick GS; Razdan RK
J Pharmacol Exp Ther; 1995 Jun; 273(3):1235-44. PubMed ID: 7791096
[TBL] [Abstract][Full Text] [Related]
6. Noradrenergic and purinergic involvement in spinal antinociception by 5-hydroxytryptamine and 2-methyl-5-hydroxytryptamine.
Sawynok J; Reid A
Eur J Pharmacol; 1991 Nov; 204(3):301-9. PubMed ID: 1663459
[TBL] [Abstract][Full Text] [Related]
7. Spinal cholinergic and monoamine receptors mediate the antinociceptive effect of morphine microinjected in the periaqueductal gray on the rat tail, but not the feet.
Fang F; Proudfit HK
Brain Res; 1996 May; 722(1-2):95-108. PubMed ID: 8813354
[TBL] [Abstract][Full Text] [Related]
8. Antinociceptive mechanisms of platycodin D administered intracerebroventricularly in the mouse.
Choi SS; Han EJ; Lee TH; Lee JK; Han KJ; Lee HK; Suh HW
Planta Med; 2002 Sep; 68(9):794-8. PubMed ID: 12357389
[TBL] [Abstract][Full Text] [Related]
9. Effects of intrathecally administered methysergide and yohimbine on microstimulation-produced antinociception in the rat.
Barbaro NM; Hammond DL; Fields HL
Brain Res; 1985 Sep; 343(2):223-9. PubMed ID: 2996695
[TBL] [Abstract][Full Text] [Related]
10. The noradrenergic component contributing to spinal fentanyl-induced antinociception is supraspinally mediated.
Crisp T; Stafinsky JL; Perni VC; Uram M
Gen Pharmacol; 1992 Nov; 23(6):1087-91. PubMed ID: 1336747
[TBL] [Abstract][Full Text] [Related]
11. Central and systemic morphine-induced antinociception in mice: contribution of descending serotonergic and noradrenergic pathways.
Wigdor S; Wilcox GL
J Pharmacol Exp Ther; 1987 Jul; 242(1):90-5. PubMed ID: 3612540
[TBL] [Abstract][Full Text] [Related]
12. Antinociceptive response to nitrous oxide is mediated by supraspinal opiate and spinal alpha 2 adrenergic receptors in the rat.
Guo TZ; Poree L; Golden W; Stein J; Fujinaga M; Maze M
Anesthesiology; 1996 Oct; 85(4):846-52. PubMed ID: 8873555
[TBL] [Abstract][Full Text] [Related]
13. The heroin metabolite, 6-monoacetylmorphine, activates delta opioid receptors to produce antinociception in Swiss-Webster mice.
Rady JJ; Aksu F; Fujimoto JM
J Pharmacol Exp Ther; 1994 Mar; 268(3):1222-31. PubMed ID: 8138935
[TBL] [Abstract][Full Text] [Related]
14. Antagonism of stimulation-produced antinociception by intrathecal administration of methysergide or phentolamine.
Hammond DL; Yaksh TL
Brain Res; 1984 Apr; 298(2):329-37. PubMed ID: 6326954
[TBL] [Abstract][Full Text] [Related]
15. Differential blockade of the antinociceptive effects of centrally administered cannabinoids by SR141716A.
Welch SP; Huffman JW; Lowe J
J Pharmacol Exp Ther; 1998 Sep; 286(3):1301-8. PubMed ID: 9732392
[TBL] [Abstract][Full Text] [Related]
16. Involvement of dynorphin B in the antinociceptive effects of the cannabinoid CP55,940 in the spinal cord.
Pugh G; Mason DJ; Combs V; Welch SP
J Pharmacol Exp Ther; 1997 May; 281(2):730-7. PubMed ID: 9152379
[TBL] [Abstract][Full Text] [Related]
17. Dynorphin B and spinal analgesia: induction of antinociception by the cannabinoids CP55,940, Delta(9)-THC and anandamide.
Houser SJ; Eads M; Embrey JP; Welch SP
Brain Res; 2000 Feb; 857(1-2):337-42. PubMed ID: 10700588
[TBL] [Abstract][Full Text] [Related]
18. Centrally-mediated antinociceptive action of RWJ-22757 (formerly McN-5195): involvement of spinal descending inhibitory pathways (an hypothesis).
Vaught JL; Raffa RB
Life Sci; 1991; 48(23):2233-41. PubMed ID: 2046456
[TBL] [Abstract][Full Text] [Related]
19. Heroin acts on different opioid receptors than morphine in Swiss Webster and ICR mice to produce antinociception.
Rady JJ; Roerig SC; Fujimoto JM
J Pharmacol Exp Ther; 1991 Feb; 256(2):448-57. PubMed ID: 1847196
[TBL] [Abstract][Full Text] [Related]
20. Neurotropin induces antinociceptive effect by enhancing descending pain inhibitory systems involving 5-HT3 and noradrenergic alpha2 receptors in spinal dorsal horn.
Kawamura M; Ohara H; Go K; Koga Y; Ienaga K
Life Sci; 1998; 62(24):2181-90. PubMed ID: 9627076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
